Select language:  
1800 620 420
Close menu

Could the immune system hold the key to curing follicular lymphoma?

A world-first research group is investigating a new therapeutic approach.

  • Non-Hodgkin lymphoma
  • Research
Read more
Professor Maher Gandhi

Q&A with Kimberly Stegmaier

Kimberly Stegmaier's research focuses on finding new therapeutic targets for children with cancer.

  • Acute myeloid leukaemia
  • Research
Read more
Kimberly Stegmaier

Bone density treatment slows progression of leukaemia

  • Acute lymphoblastic leukaemia
  • Media releases
Read more
Illustration of a microscope, test tubes, and clipboard

Improving the “wait and see” approach to treatment for high-risk blood cancer

Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan

Improving lymphoma outcomes with personal touch

Professor Gandhi discusses how personalised treatment is improving outcomes for people with Hodgkin lymphoma.

  • Hodgkin lymphoma
Read more
Professor Maher Gandhi

Breakthrough therapy gives hope for new leukaemia treatment

  • Chronic lymphocytic leukaemia
  • Research
Read more
Illustration of various treatments, pills, medicines

Targeting cancer ‘survival’ protein to kill cancer cells

A protein critical for the survival of many cancer cells might be the key to a new treatment for lymphoma and leukaemia patients.

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Research
Read more
Dr Stephanie Grabow. Photo courtesy of the Walter and Eliza Hall Institute of Medical Research.

A vital head start against cancer

Professor Maher Gandhi talks about improving outcomes for patients with DLBCL.

  • Non-Hodgkin lymphoma
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard